Selank 10MG is a research-use-only peptide designed for laboratory applications. This compound is intended for advanced biochemical and pharmacological studies. For research use only. Results may vary depending on experimental conditions.
Price range: $35.00 through $65.00
Every serious peptide company prominently displays this. Example Research Use Only All products offered by Dakota Peptology are intended strictly for laboratory research purposes.
Every serious peptide company prominently displays this. Example Research Use Only All products offered by TruPeptides are intended strictly for laboratory research purposes.
‘
Selank is a synthetic peptide derived from the brain’s neurotrophic factors, originally identified for its potential effects on stress resilience, cognitive function, and neuroprotective properties. This product is intended for academic and industrial research applications only, designed to facilitate studies in peptide chemistry, biological mechanisms, and related scientific investigations. It is important to note that Selank 10MG is not intended for therapeutic, diagnostic, or consumer use.
Selank, also known as “brain-derived peptide,” was first isolated in 2010 from the brains of rats. Its structure, consisting of 10 amino acids, shares similarities with endogenous neurotrophic factors, particularly those involved in stress adaptation and neuronal plasticity. Research has explored its potential roles in modulating mood, cognitive performance, and neuroendocrine responses under stress conditions. While its mechanisms remain under investigation, Selank has demonstrated promising effects in preclinical studies, particularly in animal models.
The primary rationale for using Selank in research settings stems from its ability to enhance neuronal resilience and modulate stress-related pathways. Initial studies in rodents have shown that Selank administration may reduce anxiety-like behaviors, improve learning and memory retention, and exhibit neuroprotective effects against excitotoxicity. These findings have generated interest in its potential applications in fields such as neurology, pharmacology, and behavioral science. However, it is crucial to emphasize that the findings reported to date are limited to in vitro and animal studies and have not yet been confirmed in human trials.
This product is supplied for research purposes exclusively and is intended solely for use by qualified professionals within an accredited academic or industrial research setting. Users must adhere to all applicable laboratory protocols, regulatory guidelines, and institutional ethical standards. Due to its biological nature, Selank requires careful handling, including appropriate storage conditions (e.g., refrigeration at 2–8°C) to maintain stability and integrity. Researchers are advised to conduct thorough safety assessments, including toxicity testing, prior to experimentation.
For research use only. Not for human or animal consumption.
Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin.
It has been studied for its neuroregulatory and anxiolytic properties, particularly in relation to neurotransmitter balance and stress response modulation.
The referenced study aimed to evaluate the effects of Selank on morphine withdrawal symptoms and behavioral responses in dependent subjects.
Researchers focused on its potential to reduce anxiety-related and aversive physiological signs.
In this study, Selank was administered to rats undergoing naloxone-precipitated morphine withdrawal.
Behavioral and physiological parameters were measured, including convulsive reactions, posture disturbances, and tactile sensitivity thresholds.
Selank significantly reduced the overall index of morphine withdrawal syndrome by approximately 39.6%.
It also attenuated convulsive reactions, improved posture abnormalities, and increased sensitivity thresholds, indicating reduced stress and discomfort.
Selank is believed to modulate neurotransmitter systems, particularly GABAergic pathways, contributing to its anxiolytic effects.
It also exhibits immunomodulatory activity and may influence neurochemical balance related to stress and emotional regulation.
These findings support Selank as a compound of interest in research related to anxiety, stress adaptation, and neurochemical regulation.
Its non-benzodiazepine-like profile suggests potential advantages in studying alternative pathways for anxiolytic effects.
Selank demonstrated significant reduction in withdrawal-related symptoms and stress responses in controlled preclinical models.
These results support continued investigation into its role in neuroregulation and behavioral research.
